Loading clinical trials...
Loading clinical trials...
ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) With Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
Conditions
Interventions
Omitted Doxorubicin
Omitted Vincristine+Dexamethasone pulses
+4 more
Locations
139
Belgium
L'hôpital Universitaire des enfants Reine Fabiola (Huderf)
Brussels, Belgium
Cliniques Universitaires Saint-Luc (UCL)
Brussels, Belgium
University Hospital Antwerp
Edegem, Belgium
University Hospital Ghent
Ghent, Belgium
University Hospital Leuven, Dept of Paediatrics
Leuven, Belgium
CHC MontLégia, Boulevard Patience et Beaujonc 2
Liège, Belgium
Start Date
July 13, 2020
Primary Completion Date
June 1, 2033
Completion Date
June 1, 2033
Last Updated
March 27, 2026
NCT06855810
NCT06101381
NCT06626893
NCT06482281
NCT02393859
NCT04942730
Global Clinical Trial Manager ALLTogether1
CONTACT
+46 8 123 700 00alltogether.karolinska@regionstockholm.seLead Sponsor
Mats Heyman
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions